Screening for Barrett's Esophagus in Colonoscopy Patients with and without Heartburn

Gastroenterology

Volumn 125, Issue 6, 2003, Pages 1670-1677

  Rex, Douglas K ^a,e   Cummings, Oscar W ^a   Shaw, Michael ^b   Cumings, Mark D ^c   Wong, Roy K H ^c   Vasudeva, Raj S ^d   Dunne, Donal ^a   Rahmani, Emad Y ^a   Helper, Debra J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PARK NICOLLET INSTITUTE   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

^e INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BARRETT ESOPHAGUS; CARDIA; COLONOSCOPY; COLUMNAR EPITHELIUM; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ESOPHAGUS BIOPSY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEARTBURN; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MULTIVARIATE ANALYSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RACE DIFFERENCE; STOMACH BIOPSY; SYMPTOM;

EID: 0344628832     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.09.030     Document Type: Article

References (57)

1. Daly JM, Kamell LH, Menck HR. National Cancer Data Base report on esophageal carcinoma. Cancer 1996;78:1820-1828.
2. Bytzer P, Christensen PB, Damkier P, Vinding K, Seersholm N. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol 1999;94:86-91.
3. Blot WJ, Devesa SS, Kneller RW, Graumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-1289.
4. Lagergren J, Bergstorm R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-831.
5. Stein HJ, Siewert JR. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management. Dysphagia 1993;8:276-288.
6. Altorki NK, Skinner DB. Adenocarcinoma in Barrett's esophagus. Semin Surg Oncol 1990;6:274-278.
7. Haggitt RC, Tryzelaar J, Ellis FH, Colcher HI. Adenocarcinoma complicating columnar epithelial lined (Barrett's) esophagus. Am J Clin Pathol 1978;70:1-5.
8. Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983;198:554-565.
9. Smith RR, Hamilton SR, Boitnott JK, Rogers EL. The spectrum of carcinoma arising in Barrett's esophagus. Am J Surg Pathol 1984;8:563-573.
10. Rosenberg JC, Budey H, Edwards RC, Singal S, Steiger Z, Sundareson AS. Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system. Cancer 1985;55:1353-1360.
11. Paraf F, Flejou JF, Pignon JP, Fekete F, Potet F. Surgical pathology of adenocarcinoma arising in Barrett's esophagus. Am J Surg Pathol 1995;19:183-191.
12. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction in Barrett's esophagus. Gastroenterology 1995;109:1541-1546.
13. Clark GW, Smyrk TC, Budiles P, Hoeft SF, Peters JH, Kiyabu M, Hinder RA, Bremner CG, DeMeester TR. Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609-614.
14. MacDonald WC, MacDonald JB. Adenocarcinoma of the esophagus and/or gastric cardia. Cancer 1987;60:1094-1098.
15. Sampliner RE. The Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888-1895.
16. Robertson CS, Mayberry JF, Nicholson DA, James PD, Atkinson M. Value of endoscopic surveillance in the detection of neoplastic change in Barrett's esophagus. Br J Surg 1988;75:760-763.
17. Cederqvist C, Nielsen J, Berthelsen A, Hansen HS. Cancer of the esophagus. II. Therapy and outcome. Acta Chir Scand 1978;144:233-240.
18. Skinner DB. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 1983;85:59-71.
19. Ellis FH Jr, Gibb SP, Watkins E Jr. Esophagogastrectomy. A safe, widely applicable, and expeditious form of palliation for patients with carcinoma of the esophagus and cardia. Ann Surg 1983;198:531-540.
20. Galandiuk S, Hermann RE, Cosgrove DM, Gassman JJ. Cancer of the esophagus. The Cleveland Clinic experience. Ann Surg 1986;203:101-108.
21. DeMeester TR, Zaninotto G, Johansson KE. Selective therapeutic approach to cancer in the lower esophagus and cardia. J Thorac Cardiovasc Surg 1988;95:42-54.
22. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26:487-494.
23. Dulai G, Guha S, Kahn K, Gornbein J, Weinstein W. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology 2002;122:26-33.
24. Shaheen NJ, Provenzale D, Sandler RS. Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma: a review of the evidence. Am J Gastroenterol 2002;97:1319-1327.
25. Vaughan TL, Davis S, Kristal A, Thomas DB. Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995;4:85-92.
26. Brown LM, Swanson CA, Gridley G, Swanson GM, Schoenberg JB, Greenberg RS, Swanson GM, Liff JM, Schwartz AG, Hayes RB, Blot WJ. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 1995;87:104-109.
27. Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors of esophageal adenocarcinoma. Am J Gastroenterol 2002;97:1930-1936.
28. Menke-Pluymers MB, Hop WCJ, Dees J, van Blankenstein M, Tilanus HW. Risk factors for the development of adenocarcinoma in columnar-lined (Barrett) esophagus. Cancer 1993;72:1155-1158.
29. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, Mitchell B, Beveridge BR, Laurence BH, Gibson GG. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-912.
30. Shaw M, Talley NJ, Adlis S, Beebe T, Tomshine P, Healey MI. Development of a digestive health status instrument: tests of scaling assumptions, structure, and reliability in a primary care population. Aliment Pharmacol Ther 1998;12:1067-1078.
31. Dhillon S, Romero Y, Harmsen S, Beri G, Schleck C, Zinsmeister A. Concurrent validity and reproducibility characteristics of the reflux symptoms questionnaire and the reflux symptoms questionnaire 1-W. Am J Gastroenterol 2002;97:S243.
32. Locke GR, Talley NJ, Weaver AL, Zinsmeister ARI. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994;69:539-547.
33. Hosmer DW, Lemeshow S. Applied logistic regression. (2nd edition). New York: Wiley, 2000.
34. Hirota W, Loughney T, Lazas D, Maydonovitch CL, Rholl W, Wong RK. Specialized intestinal metaplasia, dysplasia and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999;116:277-285.
35. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK. Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994;344:1533-1536.
36. Trudgill NJ, Suvarna SK, Kapur KC, Riley SA. Intestinal metaplasia at the squamo-columnar junction in patients attending for diagnostic gastroscopy. Gut 1997;41:585-589.
37. Johnston MH, Hammond AS, Laskin W, Jones DM. The prevalence and clinical characterisitics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 1996;91:1507-1511.
38. Nandurkar S, Talley NJ, Martin CJ, Ng TH, Adams S. Short segment Barrett's oesophagus: prevalence, diagnosis and associations. Gut 1997;40:710-715.
39. Ormsby AH, Vaezi MF, Richter JE, Goldblum JR, Rice TW, Falk GW, Gramlich TL. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 2000;119:683-690.
40. El-Zimaity HM, Graham DY. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens. Am J Gastroenterol 2001;96:1378-1382.
41. Vaira D, Vakil N. Blood, urine, stool, breath, money, and Helicobacter pylori. Gut 2001;48:287-289.
42. Ransom JM, Patel GR, Cliff SA, Womble NE, Read RCI. Extended and limited types of Barrett's esophagus in the adult. Ann Thorac Surg 1982;33:19-27.
43. Harle IA, Finley RJ, Belsheim M, Bondy DC, Booth M, Lloyd OD, McDonald JW, Sullivan S, Valberg LS, Watson WC. Management of adenocarcinoma in columnar-lined esophagus. Ann Thorac Surg 1985;40:330-336.
44. Rudolph RE, Vaughan TL, Storer BE, Haggitt RC, Rabinovitch PS, Levine DS, Reid BJ. Effect of segment length on risk for neoplastic progression in patients with Barrett's esophagus. Ann Intern Med 2000;132:612-620.
45. Weston AP, Badr AS, Hassanein RS. Prospective multivariate analysis of clinical, endoscopic, and histologic factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999;94:3413-3419.
46. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002;123:461-467.
47. Weston AP, Krmpotich P, Makdisi WF, Cherian R, Dixon A, McGregor DH, Banerjee SK. Short segment Barrett's esophagus. Clinical and histologic features, associated endoscopic findings, and associations with gastric intestinal metaplasia. Am J Gastroenterol 1996;91:981-986.
48. Weston AP, Krmpotich P, Cherian R, Dixon A, Topalovski M. Prospective evaluation of intestinal metaplasia and dysplasia within the cardia of patients with Barrett's esophagus. Dig Dis Sci 1997;42:597-602.
49. Sharma P, Morales T, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short segment Barrett's esophagus - a prospective 3 year follow-up. Am J Gastroenterol 1997;92:2012-2016.
50. Hamilton S, Smith R, Cameron J. Prevalence and characteristics of Barrett's esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988;19:942-948.
51. Rudolph R, Vaughan T, Storer B, Haggitt RC, Rabinovitch PS, Levine DS, Reid BJ. Effect of segment length on risk for neoplastic progression in patients with Barrett's esophagus. Ann Intern Med 2000;132:612-620.
52. Schnell T, Sontag S, Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci 1992;37:137-143.
53. Guelrud M, Herrera I, Essenfeld H, Castro J. Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus. Gastrointest Endosc 2001;53:559-565.
54. Sharma P, Weston A, Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia dysplasia in Barrett's esophagus. (abstr) Gastrointest Endosc 2001;53: AB63(329).
55. Canto MI, Setrakian S, Willis J, Chak A, Petras R, Powe NR, Sivak MV Jr. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest Endosc 2000;51:560-568.
56. Kiesslich R, Hahn M, Herrmann G, Jung M. Screening for specialized columnar epithelium with methylene blue: chromoendoscopy in patients with Barrett's esophagus and a normal control group. Gastrointest Endosc 2001;53:47-52.
57. Sharma P, Topalovski M, Mayo MS, Weston AP. Methylene blue chromoendoscopy for detection of short segment Barrett's esophagus. Gastrointest Endosc 2001;54:289-293.